With global acceptance of oral ERAs, the global pulmonary hypertension market expected to surpass US $3 billion by 2019, says Technavio
Pulmonary Hypertension: Key market research findings Increased focus towards combination therapies Introduction of new disease-modifying drugs Technavio has added a new market research report on the global pulmonary hypertension market to its pulmonary disease portfolio. Technavio’s market research analysts estimate the pulmonary hypertension market to grow at a CAGR of around 3% between 2015…
